SCHEMBL19856464

SCHEMBL19856464

CN(C)c1cccc2c(S(=O)(=O)N3CCNCCNCC3)cccc12

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.75
ATM Q13315 1/20 0.75
CYP3A4 P08684 4/20 0.59
NFKB1 P19838 3/20 0.59
CYP1A2 P05177 3/20 0.59
TP53 P04637 2/20 0.59
CYP2D6 P10635 2/20 0.59
MAPK1 P28482 2/20 0.59
MYLK Q15746 2/20 0.59
MEN1 O00255 1/20 0.59
CYP2C9 P11712 1/20 0.59
LMNA P02545 3/20 0.57
ROCK1 Q13464 3/20 0.57
GMNN O75496 2/20 0.57
TSHR P16473 2/20 0.57
MAPT P10636 2/20 0.57
CYP2C19 P33261 2/20 0.57
MTOR P42345 1/20 0.57
RAB9A P51151 1/20 0.57
PMP22 Q01453 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18138090 1.00 KMT2A (0.75) KMT2AATMCYP3A4NFKB1CYP1A2
SCHEMBL31033068 0.99 KMT2A (0.77) KMT2AATMCYP3A4NFKB1CYP1A2
SCHEMBL5650140 0.99 KMT2A (0.77) KMT2AATMCYP3A4NFKB1CYP1A2
SCHEMBL29437927 0.89 KMT2A (0.88) KMT2AATMCYP1A2MEN1CYP2C19
SCHEMBL25531 0.89 KMT2A (0.88) KMT2AATMCYP1A2MEN1CYP2C19
SCHEMBL15934204 0.83 KMT2A (0.79) KMT2AATMCYP1A2MEN1LMNA
SCHEMBL14256516 0.81 KMT2A (0.75) KMT2AATMCYP1A2MEN1CYP2C19
SCHEMBL12604576 0.81 KMT2A (0.75) KMT2AATMCYP1A2MEN1CYP2C19
SCHEMBL29678142 0.81 KMT2A (0.70) KMT2AATMCYP1A2CYP2C19HIF1A
SCHEMBL32677285 0.80 KMT2A (0.74) KMT2AATMCYP1A2TSHRCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180369428-A1 RADIOACTIVE PROBE FOR DETECTING HYDROGEN SULFIDE KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY- ACADEMIC COOPERATION FOUNDATION (KR) 2018-12-27 US claimed
EP-3281643-A2 RADIOACTIVE PROBE FOR DETECTING HYDROGEN SULFIDE Kyungpook National University Industry-Academic Cooperation Foundation (KR) 2018-02-14 EP claimed
US-20200138982-A1 RADIOACTIVE PROBE FOR DETECTING HYDROGEN SULFIDE KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY- ACADEMIC COOPERATION FOUNDATION (KR) 2020-05-07 US disclosed
US-20200138982-A1 RADIOACTIVE PROBE FOR DETECTING HYDROGEN SULFIDE KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY- ACADEMIC COOPERATION FOUNDATION (KR) 2020-05-07 US disclosed
US-10583206-B2 Radioactive probe for detecting hydrogen sulfide Kyungpook National University Industry-Academic, Cooperation Foundation (KR) 2020-03-10 US disclosed
US-20180369428-A1 RADIOACTIVE PROBE FOR DETECTING HYDROGEN SULFIDE KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY- ACADEMIC COOPERATION FOUNDATION (KR) 2018-12-27 US disclosed
EP-3281643-A2 RADIOACTIVE PROBE FOR DETECTING HYDROGEN SULFIDE Kyungpook National University Industry-Academic Cooperation Foundation (KR) 2018-02-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180369428-A1 RADIOACTIVE PROBE FOR DETECTING HYDROGEN SULFIDE TST, CTH, CBS KMT2A 4501/4885ATM 1485/4885CYP3A4 3262/4885
US-20200138982-A1 RADIOACTIVE PROBE FOR DETECTING HYDROGEN SULFIDE TST, SCLY, CTH KMT2A 4261/4885ATM 1572/4885CYP3A4 3156/4885
US-10583206-B2 Radioactive probe for detecting hydrogen sulfide TST, SCLY, CTH KMT2A 4261/4885ATM 1572/4885CYP3A4 3156/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.